FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and concerns a method for prediction of haematogenic metastasis in invasive breast cancer of non-specific type in patients irrespective of the treatment. That is ensured by histologic assessment of the tissue of the infiltrative tumour component. If observing single tumour cells, a high risk of haematogenous metastasis is predicted.
EFFECT: invention enables predicting the risk of haematogenic metastasis in the patients with invasive breast carcinoma with the most informative value and minimum costs.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR HEMATOGENOUS METASTASIS PREDICTION IN CASE OF NON-SPECIFIC INVASIVE BREAST CARCINOMA FOR PATIENTS WITH BAD RESPONSE TO NEOADJUVANT CHEMOTHERAPY | 2016 |
|
RU2623150C1 |
| METHOD FOR HEMATOGENIC METASTASING PREDICTION IN CASE OF NON-SPECIFIC INVASIVE CARCINOMA OF BREAST IN PATIENTS WITH GOOD RESPONSE TO NEOADJUVANT CHEMOTHERAPY | 2016 |
|
RU2627649C1 |
| METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN DOUBLE-SIDED SYNCHRONOUS INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2015 |
|
RU2589287C1 |
| METHOD FOR PREDICTION OF HAEMATOGENOUS METASTASIS IN TRIPLE NEGATIVE INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2014 |
|
RU2558863C1 |
| METHOD FOR PREDICTING LYMPHOGENOUS METASTASIS IN INVASIVE CARCINOMA OF NONSPECIFIC TYPE OF MAMMARY GLAND | 2016 |
|
RU2659938C2 |
| METHOD FOR PREDICTING THE DEGREE OF RISK OF DEVELOPING HEMATOGENOUS METASTASES IN INVASIVE CARCINOMA OF A NON-SPECIFIC TYPE OF MAMMARY GLAND BASED ON THE ASSESSMENT OF THE EXPRESSION OF LIMCH1 PROTEIN | 2020 |
|
RU2755242C1 |
| METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN DOUBLE-SIDED METACHROMIC INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2015 |
|
RU2580639C1 |
| METHOD OF PREDICTING NODAL METASTASIS IN TWO-WAY SYNCHRONOUS INVASIVE CARCINOMA OF NON-SPECIFIC TYPE OF MAMMARY GLANDS | 2015 |
|
RU2578462C1 |
| METHOD FOR PREDICTING THE RISK OF POOR TUMOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH INVASIVE BREAST CANCER | 2018 |
|
RU2682967C1 |
| METHOD FOR PREDICTING RISK OF LYMPHATIC CANCER SPREAD IN BREAST CANCER BASED ON YKL-39 PROTEIN GENE EXPRESSION | 2016 |
|
RU2632115C1 |
